Patent · US Active

Pyrido [3,4-C] [1,9] phenanthroline and 11, 12 dihydropyrido [3,4-C] [1,9] phenanthroline derivatives and the use thereof, particularly for treating cancer

US9062054B2 · kind B2 · utility

2Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2013
Grant dateJun 23, 2015
Priority date
Expiry dateApr 5, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

New phenanthroline derivatives as drug as well as methods for producing said compounds are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.